What is MammoSite Targeted Radiation Therapy? Banner
Email Page Print Page

Clinical Trial Data

There have been several clinical studies since the MammoSite® Radiation Therapy System received FDA clearance in 2002.

5-year Initial Clinical Trial Results (N=43):6

  • No local recurrences
  • 83.3% of the patients had good/excellent cosmetic results
  • 100% of patients in the initial clinical trial would recommend MammoSite to a friend or family member.
  • 100% of patients in the initial clinical trial would use MammoSite again if they had to do it over.